AAKP’s Innovator Series highlights companies, researchers, and professionals in the field of nephrology committed to making a difference, improving care, and changing the status quo. In this Innovator article, AAKP features Humacyte. Humacyte was also featured in aakpRENALIFE in March 2018: https://bit.ly/Humacyte2018.Humacyte, Inc.

In 2001, Adam Akers was a young and active 29-year-old living in rural Iowa on an 80-acre farm. He worked as a laborer in construction full-time and was active in the Iowa Army National Guard. Married with two children, he had a small grain farm, raised pigs, and kept himself in good shape.

Stephen Fadem, MD, FACP, FASN, AAKP Medical Advisory Board ChairThe influenza, more commonly known as the “flu,” is a virus that mostly affects the respiratory tract. It is transmitted by tiny droplets of moisture from person to person through coughing, sneezing, or even talking.

An Innovative Breakthrough: Minimally Invasive AV Fistula Creation Option for Hemodialysis PatientsLearn more about endoAVF and how it compares to the standard surgical arteriovenous (AV) fistula creation.

AAKP 46th Annual National Patient Meeting Mobilizing for Innovation and Independence Day Two (9/25/21) - Closing Remarks Transcribed from closing remarks made by Richard Knight, AAKP President AAKP President Richard Knight Hello again, everyone. The past two days have been exciting.